Published in Curr Atheroscler Rep on November 01, 2004
Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev (2011) 1.24
Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans. Obesity (Silver Spring) (2009) 0.99
Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome. Hepatology (2008) 0.97
Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab (2008) 0.95
Genotype x adiposity interaction linkage analyses reveal a locus on chromosome 1 for lipoprotein-associated phospholipase A2, a marker of inflammation and oxidative stress. Am J Hum Genet (2006) 0.93
Contribution of visceral fat accumulation to carotid intima-media thickness in a Chinese population. Int J Obes (Lond) (2011) 0.93
High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner. Free Radic Biol Med (2013) 0.88
HIV and general cardiovascular risk. J Assoc Nurses AIDS Care (2011) 0.87
A Mediterranean dietary intervention in persons at high risk of colon cancer: recruitment and retention to an intensive study requiring biopsies. Contemp Clin Trials (2012) 0.86
The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells. J Med Food (2009) 0.79
Ghrelin Does not Alter Aortic Intima-Media Thickness and Adipose Tissue Characteristics in Control and Obese Mice. Iran J Basic Med Sci (2013) 0.76
Effects of martial arts exercise on body composition, serum biomarkers and quality of life in overweight/obese premenopausal women: a pilot study. Clin Med Insights Womens Health (2013) 0.75
Obesity is associated with atypia in breast ductal lavage of women with proliferative breast disease. Cancer Epidemiol (2009) 0.75
Association between anthropometric measures of obesity, metabolic disturbances and polymorphism G-308A of the tumor necrosis factor-alpha gene in children. Eur J Med Res (2010) 0.75
Resistin increases the expression of NOD2 in mouse monocytes. Exp Ther Med (2017) 0.75
Platelet activation in obese women: role of inflammation and oxidant stress. JAMA (2002) 2.79
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol (2009) 2.11
Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis (2008) 1.96
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radic Biol Med (2007) 1.88
Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med (2007) 1.67
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol (2003) 1.39
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. Circ J (2015) 1.39
Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal (2005) 1.37
Soluble forms of RAGE in internal medicine. Intern Emerg Med (2009) 1.28
Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab (2003) 1.22
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem (2009) 1.18
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation (2003) 1.16
Soluble CD40 ligand plasma levels in lung cancer. Clin Cancer Res (2004) 1.15
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation (2002) 1.09
Diabetes mellitus and thrombosis. Thromb Res (2011) 1.04
Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol (2006) 1.00
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. J Am Coll Cardiol (2005) 0.97
Biomarkers of platelet activation in acute coronary syndromes. Thromb Haemost (2012) 0.94
Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Lab Invest (2002) 0.94
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J (2010) 0.93
Determinants of F2-isoprostane biosynthesis and inhibition in man. Chem Phys Lipids (2004) 0.92
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. J Immunol Methods (2012) 0.89
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal (2012) 0.88
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. J Infect (2008) 0.88
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol (2005) 0.88
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. Blood (2008) 0.85
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. Atherosclerosis (2010) 0.85
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke (2005) 0.84
Isoprostane formation and inhibition in atherothrombosis. Curr Opin Pharmacol (2005) 0.84
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radic Biol Med (2012) 0.83
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev (2008) 0.83
Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging (2006) 0.83
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. Intern Emerg Med (2010) 0.83
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. J Am Heart Assoc (2013) 0.83
Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal (2004) 0.82
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. Clin Sci (Lond) (2008) 0.82
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. Thromb Haemost (2009) 0.82
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. Free Radic Biol Med (2010) 0.81
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. Int J Cardiol (2013) 0.81
Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. J Clin Endocrinol Metab (2012) 0.81
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. Thromb Haemost (2010) 0.81
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol (2004) 0.81
Oxidative Stress Modulation Through Habitual Physical Activity. Curr Pharm Des (2016) 0.81
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. Thromb Haemost (2013) 0.80
Association between serum leptin levels and 24-hour blood pressure in obese women. Obes Res (2003) 0.79
Determinants of platelet activation in hypertensives with microalbuminuria. Free Radic Biol Med (2009) 0.78
Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs? Nat Clin Pract Rheumatol (2007) 0.78
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. Stress (2011) 0.78
Cardiovascular risk and dietary sugar intake: is the link so sweet? Intern Emerg Med (2011) 0.78
Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study. Thromb Haemost (2016) 0.78
Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients. Br J Haematol (2009) 0.77
Inherited bleeding disorders: results from the Italian Regional Haemophilia Centre of Pescara. Blood Transfus (2008) 0.77
Low-density lipoprotein-lowering medication and platelet function. Pathophysiol Haemost Thromb (2006) 0.77
CD40-CD40L interactions in platelet activation. Thromb Haemost (2005) 0.77
Homocysteine modulates the CD40/CD40L system. J Am Coll Cardiol (2007) 0.77
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med (2014) 0.77
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation. Thromb Res (2009) 0.76
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. Thromb Haemost (2012) 0.76
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. Clin Chim Acta (2007) 0.76
Relationship between factor XII deficiency and thrombosis: the debate is still open? J Thromb Thrombolysis (2009) 0.75
Beyond hyperglycemia in diabetes: role of statin treatment on thrombogenesis triggered by inflammation: Editorial to: "Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generations assay" by P. Ferroni et al. Cardiovasc Drugs Ther (2012) 0.75
Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection. BMC Infect Dis (2014) 0.75
Reply: ankle-brachial index in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol (2013) 0.75
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy. Oncologist (2014) 0.75
Thrombin as a common downstream target blocking both platelet and monocyte activation. Thromb Haemost (2009) 0.75
Coagulation and infective endocarditis: sooner or later. Intern Emerg Med (2015) 0.75
Circulating transforming growth factor-beta1 levels in asymptomatic carotid plaques. Stroke (2005) 0.75
A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells. PLoS One (2012) 0.75
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors. Curr Drug Targets (2015) 0.75
Recombinant activated factor VII therapy in acquired hemophilia of the elderly. Aging Clin Exp Res (2004) 0.75
Severe non-traumatic bleeding, the answer is not in the blood. Intern Emerg Med (2015) 0.75
Erratum to: medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med (2015) 0.75
[The "problem obesity": viewpoint of the internist]. Ann Ital Chir (2006) 0.75
Managing patients with low-risk MDS. Clin Adv Hematol Oncol (2006) 0.75
Four recurrent intracerebral haemorrhages. Cerebrovasc Dis (2003) 0.75
Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department. Clin Chim Acta (2007) 0.75
[New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia]. Recenti Prog Med (2004) 0.75